Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06024395 · ClinicalTrials.gov registry record · NA
A Stepped Care Approach to Treating Dental Fear
A NA study of Dental Fear, sponsored by New York University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,250
- Enrollment target
- 1
- Study location
NCT06024395: Recruiting NA study of Dental Fear, sponsored by New York University.
NCT06024395 is a NA study of Dental Fear that is actively recruiting participants, run by New York University. The registered enrollment target is 1,250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06024395, a NA study of Dental Fear, is actively recruiting participants, sponsored by New York University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,250 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare an intervention for dental fear to the usual approach (i.e., whatever participants' dentist typically does to help participants manage their fear). The dental fear intervention has 2 separate steps. Step 1 (the less intensive or 'light touch' intervention step) involves using a mobile application (app). Step 2 consists of a one-hour telehealth session with a mental health provider tailored to individualized dental fear. This is a randomized study. The time spent participating in the study will depend on which study condition(s) participants are randomly assigned to. Because this study compares the dental fear intervention to the standard approach, 25% of participants will not get the intervention during the study period. These participants (called controls) will be offered the opportunity to provide feedback about their experiences with dentists. Participants will be offered the intervention free of charge at the conclusion of the study. For each step of the intervention (Dental FearLess app or one-on-one session) relative to treatment as usual, the investigators hypothesize that participants will show greater declines in self-reported dental fear and improved oral health-related quality of life at post-treatment and follow-up period. De-identified attendance records will be collected from dental practices.
Primary Outcome
Assess the efficacy of a CBT-based stepped-care (i.e., progressive treatment dosing) approach in the reduction of moderate to severe dental fear (measured via subjective report on IDAF).
Conditions Studied
Interventions
- BEHAVIORAL Dental FearLess
Study Locations (1)
New York
- New York University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,250 participants |
| Start Date | 2023-09-11 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT06024395 shows while recruiting
NCT06024395 is an interventional study that assigns participants to a tested intervention. Its 1,250 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% lower).
The record links to 1 condition, with Dental Fear appearing as the primary indexed condition, and to 1 intervention - of which Dental FearLess is the first listed.
NCT06024395 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06024395 about?
NCT06024395 is a clinical study titled "A Stepped Care Approach to Treating Dental Fear". The purpose of this study is to compare an intervention for dental fear to the usual approach (i.e., whatever participants' dentist typically does to help participants manage their fear). The dental fear intervention has 2 separate steps. Step 1 (the less intensive or 'light touch' intervention step...
What is the current status of trial NCT06024395?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,250 participants. The study started on 2023-09-11. Estimated completion is 2028-06-30.
What conditions does trial NCT06024395 study?
This clinical trial studies the following conditions: Dental Fear.
What interventions are being tested in trial NCT06024395?
The interventions under investigation include: Dental FearLess (BEHAVIORAL).
Who is sponsoring clinical trial NCT06024395?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06024395 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Fear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06024395's enrollment target sits among peer trials
1,250 80th of 2000 higher than 1,919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- NCT05995821 · 1,250 participants
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI